6505--Axumin (fluciclovine F 18 Injection)
Contact and place of performance
Andrew L Taylor
Not specified
Statement of Need The Corporal Michael J. Crescenz VA Medical Center s (CMCVAMC) Nuclear Medicine department requires a licensed vendor by the Nuclear Regulatory Commission to provide the radiopharmaceutical drug Axumin (fluciclovine F 18 Injection) and calibration sources. This radiopharmaceutical drug is required for a new imaging procedure that will be offered to Veterans. The Calibration sources are required for...
View moreThe Department of Veterans Affairs, specifically the Corporal Michael J. Crescenz VA Medical Center (CMCVAMC) in Philadelphia, Pennsylvania, has issued solicitation 36C24421Q0627 for the procurement of Axumin (fluciclovine F 18 Injection) and associated calibration sources. This radiopharmaceutical drug is required for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence. The selected vendor must be licensed by the Nuclear Regulatory Commission to provide these drugs and must also supply calibration sources for equipment quality control testing. Deliveries are to be made directly to the Diagnostic Imaging section of Nuclear Medicine at the Philadelphia Veterans Administration Medical Center.
The scope of work includes providing unit doses of Axumin labeled with preparation and expiration details, as well as bar-coded inserts for scanning into the facility's nuclear medicine information management system. The contractor is responsible for meeting all regulatory requirements from the FDA, NRC, DOT, and OSHA, including performing necessary quality control procedures. The government requires the capability for routine next-day delivery by 8:00 am, as well as same-day emergency delivery within a two-hour window during normal business hours. Additionally, the vendor must provide an electronic daily dose tracking system and allow for the return of unused or damaged radiopharmaceuticals for credit toward future orders.
This solicitation is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals. Responses are due by June 11, 2021, and the primary point of contact is Andrew L. Taylor. The notice includes two attachments: a Word document containing the solicitation details and a redacted Justification and Approval for other than full and open competition. All annual quantities provided in the solicitation are estimates, and the contractor will be paid based on actual items ordered and delivered on an as-needed basis.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.